Westfield Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-785,494	Closed	-$33.3M	–	267
2023 Q4	$33.3M	Sell	785,494 -188,989	-19%	-$8.01M	0.19%	166
2023 Q3	$21.3M	Buy	974,483 +398,949	+69%	+$8.71M	0.14%	167
2023 Q2	$18.3M	Buy	+575,534	New	+$18.3M	0.12%	174